CITRANATAL MEDLEY- calcium citrate, iron pentacarbonyl, ferrous fumarate, cholecalciferol, .alpha.-tocopherol, dl-, pyridoxine hydrochloride, folic acid, and doconexent capsule, gelatin coated 
Mission Pharmacal Company

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

CitraNatal Medley ®

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.

CitraNatal Medley® is a prescription prenatal/postnatal multi-vitamin/mineral soft gel with Ferr-Ease®, a dual-iron delivery comprising both a quick release and slow release iron, and DHA, an essential fatty acid. The prenatal vitamin is an oval, purple, opaque soft gel containing a greenish-gray liquid to semi-solid fill. The prenatal soft gel is printed “596” in white ink.

CitraNatal Medley is a multi-vitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

One prenatal soft gel daily or as directed by a physician.

Bottles of 30 soft gels each - NDC 00178-0896-30.

Label

CITRANATAL MEDLEY 
calcium citrate, iron pentacarbonyl, ferrous fumarate, cholecalciferol, .alpha.-tocopherol, dl-, pyridoxine hydrochloride, folic acid, and doconexent capsule, gelatin coated
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0178-0896
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
FERROUS FUMARATE (UNII: R5L488RY0Q) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION2 mg
CALCIUM CITRATE (UNII: MLM29U2X85) (CALCIUM CATION - UNII:2M83C4R6ZB) CALCIUM CITRATE ANHYDROUS62 mg
IRON (UNII: E1UOL152H7) (IRON - UNII:E1UOL152H7) IRON27 mg
CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL200 [iU]
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) (.ALPHA.-TOCOPHEROL - UNII:H4N855PNZ1) .ALPHA.-TOCOPHEROL15 [iU]
PYRIDOXINE (UNII: KV2JZ1BI6Z) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE12.5 mg
FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID1 mg
DOCONEXENT (UNII: ZAD9OKH9JC) (DOCONEXENT - UNII:ZAD9OKH9JC) DOCONEXENT200 mg
Inactive Ingredients
Ingredient NameStrength
GLYCERIN (UNII: PDC6A3C0OX)  
GELATIN (UNII: 2G86QN327L)  
LECITHIN, SUNFLOWER (UNII: 834K0WOS5G)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
ETHYL VANILLIN (UNII: YC9ST449YJ)  
D&C RED NO. 33 (UNII: 9DBA0SBB0L)  
Product Characteristics
Colorpurple (opaque) Scoreno score
ShapeCAPSULE (Soft Gel) Size15mm
FlavorImprint Code 596
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0178-0896-3030 in 1 BOTTLE; Type 0: Not a Combination Product03/20/2018
Image of Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other03/20/2018
Labeler - Mission Pharmacal Company (008117095)
Registrant - Mission Pharmacal Company (927726893)
Establishment
NameAddressID/FEIBusiness Operations
Mission Pharmacal Company927726893label(0178-0896) , pack(0178-0896)

Revised: 1/2024
Document Id: 0e10ed7c-91b7-f234-e063-6394a90ac554
Set id: 67c74737-6c8b-9aeb-e053-2a91aa0adf09
Version: 6
Effective Time: 20240108
 
Mission Pharmacal Company